Adjuvant osimertinib in EGFR-mutated non–small-cell lung cancer

David Planchard

Résultats de recherche: Contribution à un journal › Editorial

18 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	1780-1782
Nombre de pages	3
journal	New England Journal of Medicine
Volume	383
Numéro de publication	18
Les DOIs	https://doi.org/10.1056/NEJMe2029532
état	Publié - 29 oct. 2020

Accès au document

@article{f80def9007a947d8b845d991231ff014,

title = "Adjuvant osimertinib in EGFR-mutated non–small-cell lung cancer",

author = "David Planchard",

year = "2020",

month = oct,

day = "29",

doi = "10.1056/NEJMe2029532",

language = "English",

volume = "383",

pages = "1780--1782",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "18",

}

TY - JOUR

T1 - Adjuvant osimertinib in EGFR-mutated non–small-cell lung cancer

AU - Planchard, David

PY - 2020/10/29

Y1 - 2020/10/29

UR - http://www.scopus.com/inward/record.url?scp=85094854311&partnerID=8YFLogxK

U2 - 10.1056/NEJMe2029532

DO - 10.1056/NEJMe2029532

M3 - Editorial

C2 - 33113300

AN - SCOPUS:85094854311

SN - 0028-4793

VL - 383

SP - 1780

EP - 1782

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 18

ER -